financetom
Business
financetom
/
Business
/
ACM Research's Q1 Non-GAAP Earnings Decline, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ACM Research's Q1 Non-GAAP Earnings Decline, Revenue Increases
May 26, 2025 3:52 AM

05:34 AM EDT, 05/08/2025 (MT Newswires) -- ACM Research ( ACMR ) reported Q1 non-GAAP earnings Thursday of $0.46 per diluted share, down from $0.52 a year earlier.

Analysts polled by FactSet expected $0.37.

Revenue for the quarter ended March 31 was $172.3 million, compared with $152.2 million a year earlier.

Analysts polled by FactSet expected $169.7 million.

The company reiterated its 2025 revenue guidance of $850 million to $950 million. Analysts polled by FactSet expect $921.3 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mako Mining Highlights Results From RC Drilling at Las Conchitas; Up 2.7%
Mako Mining Highlights Results From RC Drilling at Las Conchitas; Up 2.7%
Mar 13, 2024
11:28 AM EDT, 03/13/2024 (MT Newswires) -- Mako Mining Corp. ( MAKOF ) was at last look up 2.7% on Wednesday after providing an update of results from the ongoing reverse circulation drill program at the new mining area, Las Conchitas. The new area is located immediately south of the company's San Albino gold mine, which is currently in commercial...
Valley National Bancorp Insider Sold Shares Worth $406,669, According to a Recent SEC Filing
Valley National Bancorp Insider Sold Shares Worth $406,669, According to a Recent SEC Filing
Mar 13, 2024
11:28 AM EDT, 03/13/2024 (MT Newswires) -- Joseph Chillura, Senior Executive Vice President, Commercial Banking, on March 11, 2024, sold 49,715 shares in Valley National Bancorp ( VLY ) for $406,669. Following the Form 4 filing with the SEC, Chillura has control over a total of 580,249 shares of the company, with 580,249 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/714310/000071431024000071/xslF345X03/wk-form4_1710343333.xml Price:...
PepGen Says Potential Duchenne Muscular Dystrophy Treatment Gets FDA Orphan Drug, Rare Pediatric Disease Designations
PepGen Says Potential Duchenne Muscular Dystrophy Treatment Gets FDA Orphan Drug, Rare Pediatric Disease Designations
Mar 13, 2024
11:32 AM EDT, 03/13/2024 (MT Newswires) -- PepGen ( PEPG ) said Wednesday that its potential Duchenne muscular dystrophy treatment PGN-EDO51 has received orphan drug and rare pediatric disease designations from the US Food and Drug Administration. The company said it is currently assessing PGN-EDO51 for the treatment of the muscle-wasting disease in the CONNECT1 phase 2 trial. The enrollment...
Why Vera Bradley Shares Are Falling Today
Why Vera Bradley Shares Are Falling Today
Mar 13, 2024
Vera Bradley, Inc. ( VRA ) shares are trading lower in the morning session on Wednesday. The company reported fourth-quarter adjusted earnings per share of 11 cents, missing the street view of 14 cents. Vera Bradley ( VRA ) reported fourth-quarter revenues of $133.265 million, missing the street view of $136.054 million. Current year fourth quarter Vera Bradley Direct segment revenues totaled $93.0 million,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved